drugset / Trial / NCT03425084
Genetic Variation in Organic Cation Transport 1 (OCT1) and Its Significance for Morphine Pharmacokinetics
Phase 1
Completed
86 enrolled
University of Southern Denmark
Danish Council for Independent Research · collabRegion of Southern Denmark · collabThe Faculty of Health Sciences SDU · collab
NaSingle-groupOpen-labelOther
Summary
The main objective of the trial is to investigate the effect of known genetic variants in organic cation transporter 1 (OCT1) on the effect of morphine after major surgery
Timeline
- Start
- 2018-06-01
- Primary completion
- 2020-02-07
- Completion
- 2020-02-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Morphine | Other / unclassified | 0.04 mg/kg | Intravenous |
Indications
No indication recorded.